Who to call at Kashiv BioSciences, and when
Fundz watches for the moments Kashiv BioSciences starts buying, and tells you who to reach.
- An alert the day Kashiv BioSciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kashiv BioSciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kashiv BioSciences. With Fundz connected, it knows.
Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab)
Contract Type
agreement
Description
Kashiv BioSciences, LLC has announced an exclusive licensing agreement with Amneal Pharmaceuticals, Inc. for ADL018, a proposed biosimilar to omalizumab referencing XOLAIR® for the United States. The biosimilar is currently in a Phase III clinical trial, targeting free IgE to treat chronic conditions such as severe persistent allergic asthma, chronic rhinosinusitis with nasal polyps, food allergies, and chronic spontaneous urticaria.
Quick answer
Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab) (July 1, 2024). Kashiv BioSciences is based in Bridgewater, New Jersey, United States.
- What agreement did Kashiv BioSciences announce on July 1, 2024?
- Kashiv BioSciences, LLC has announced an exclusive licensing agreement with Amneal Pharmaceuticals, Inc. for ADL018, a proposed biosimilar to omalizumab referencing XOLAIR® for the United States. The biosimilar is currently in a Phase III clinical trial, targeting free IgE to treat chronic conditions such as severe persistent allergic asthma, chronic rhinosinusitis with nasal polyps, food allergies, and chronic...
- What does Kashiv BioSciences do?
- Kashiv BioSciences, LLC is a company that focuses on developing and manufacturing high-quality, affordable biosimilars to improve patients’ lives worldwide.
- Where is Kashiv BioSciences based?
- Kashiv BioSciences is based in Bridgewater, New Jersey, United States.
Source: Fundz verified event record.
Related People
Kashiv BioSciences signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.